I
Market Data
$1.14−$0.14 (−10.94%)
INAB · Last trade
Prev Close
$1.28
Range (28d)
$1.01 – $1.20
Recent Filings
- SCHEDULE 13G/A12.3 KBIN8BIO, INC.Aug 13, 2:21 PM ET·0000935836-26-000398
- 10-Q10.2 MBIN8BIO, INC.Aug 6, 4:11 PM ET·0001193125-26-338012
- 8-K418.5 KBIN8BIO, INC.Aug 6, 4:05 PM ET·0001193125-26-337944
- 8-K432.1 KBIN8BIO, INC.Jun 1, 6:56 AM ET·0001193125-26-249684
- 10-Q9.1 MBIN8BIO, INC.May 7, 4:32 PM ET·0001193125-26-212135
- 8-K884.7 KBIN8BIO, INC.May 7, 4:31 PM ET·0001193125-26-212128
- 10-K37.1 MBIN8BIO, INC.Mar 12, 4:15 PM ET·0001193125-26-104181
- 8-K393.9 KBIN8BIO, INC.Mar 12, 4:10 PM ET·0001193125-26-104144
- 8-K139.9 KBIN8BIO, INC.Feb 27, 4:05 PM ET·0001193125-26-082539
- 8-K140.9 KBIN8BIO, INC.Feb 9, 8:31 AM ET·0001193125-26-041975
Insiders
10- Beelen MelissaVP, Clinical Operation
- BIOS Advisors GP, LLC10% Owner
- BIOS Capital Management, LP10% Owner
- Bios Clinical Opportunity Fund, LP10% Owner
- Bios Equity Partners II, LP10% Owner
- Bios Equity Partners, LP10% Owner
- BIOS Fund III, LP10% Owner
- BIOS Fund III QP, LP10% Owner
- BIOS Fund II, LP10% Owner
- BIOS Fund II NT, LP10% Owner
Tickers
Addresses
business
EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330
NEW YORK, NY, 10118
mailing
EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330
NEW YORK, NY, 10118
Former Names
- Incysus Therapeutics, Inc.2018-09-20